Alogliptin
- Catalog NO.:A851538
- CAS No. : 850649-61-5
- Molecular Formula:C18H21N5O2
- Molecular Weight: 339.39
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Product Details
CAS Number | 850649-61-5 | Appearance | |
Catalog Number | A851538 | MDL Number | MFCD09833196 |
Molecular Formula | C18H21N5O2 | Molecular Weight | 339.39 |
Boiling Point | 519.2°C at 760 mmHg | Melting Point | |
Flash Point | Density | ||
Synonyms | SYR-322;Nesina;Kazano;Oseni;(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile | ||
Storage Condition | Store in a tightly closed container,in a cool and dry place |
Safety
GHS Pictogram | |||
Signal Word | Warning | UN Number | |
Hazard Statements | H302-H315-H319-H335 | Class | |
Precautionary Statements | P261-P305+P351+P338 | Packing Group |
Description
Alogliptin is an orally administered anti-diabetic drug in the DPP-4 inhibitor class, developed by Syrrx, a company which was acquired by Takeda Pharmaceutical Company in 2005. Like other medications for the treatment of Type 2 diabetes, alogliptin does not decrease the risk of heart attack and stroke. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of causing hypoglycemia, and exhibits relatively modest glucose-lowering activity. Alogliptin and other gliptins are commonly used in combination with metformin in patients whose diabetes cannot adequately be controlled with metformin alone. |